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Lp lipoproteins have been prepared by a mild method from the serum of a large 
number of individuals. Approximately 25%o of the individuals tested showed 
the presence of a double Lp peak in analytical ultracentrifuge diagrams. These 
double peaks were designated Lp(a)-I and Lp(a)-2 to distinguish them from the 
single Lp(a) peak. The mean viscosity-corrected sedimentation coefficient, 
sl.oo4, 20 c, and density of the single Lp(a) peak were 15.8 +_ 1.8s (n = 32) and 
1.076++_0.01 g/ml, of the Lp(a)-I peak were 13.5+_1.1s (n = 14) and 1.064+ 
0.007 g/ml, and of the Lp(a)-2 peak were 16.8 +- 1.7s (n = 14) and 1.074 +- 0.009 
g/ml. Absorption tests using a double and single Lp preparation showed that 
both Lp peaks in the double variants possess Lp(a) specificity. Evidence is 
lacking as yet for individual specificities for either Lp(a)-I or Lp(a)-2. Inter- 
and intra-individual heterogeneity among Lp lipoproteins is discussed. 
I N T R O D U C T I O N  
The Lp(a) 3 l ipoprotein was first described by Berg (1963). Genetic studies 
reviewed by Berg (1968) indicated that  the presence or absence of the Lp(a) 
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factor was under the control of a single autosomal gene. In 1970, Harvie and 
Schultz showed that all sera tested contained the Lp lipoprotein and suggested 
the quantitative nature of the genetic control. Other investigators have con- 
firmed this finding (Utermann and Wiegandt, 1970). The Lp lipoprotein has 
been isolated from human serum by various methods involving precipitation 
with dextran sulfate, preparative and density gradient ultracentrifugation, 
and column chromatography (Wiegandt et al., 1968; Schultz et al., 1968; 
Ehnholm et al., 1971; Simons et al., 1970; Utermann and Wiegandt, 1969; 
Utermann et al., 1972). 
The Lp lipoprotein has a density between 1.064 and 1.12 g/ml, an Sf 1.21, 
20 c of approximately 24, and an estimated molecular weight of 5 × 105 (Schultz 
et al., 1968; Simons et al., 1970; Ehnholm et al., 1971). Preliminary biochemi- 
cal data indicate that Lp lipoprotein has approximately 40% protein and a 
higher carbohydrate content than LDL 4 (Ehnholm et al., 1972). The Lp 
lipoprotein shares some antigenic determinants with LDL, contains other(s) 
specific for Lp(a), and shows no cross-reactivity with HDL 4 (Schultz et al., 
1968; Wiegandt et al., 1968). Recently it has been reported by two laboratories 
(Utermann et al.~ 1972; Ehnholm et al., 1972) that Lp lipoprotein disaggre- 
gated after standing, or after treatment with detergent, into three components, 
i.e., LDL lipoprotein, Lp(a) apoprotein, and albumin. The significance of this 
finding remains to be established. 
During investigations in this laboratory of the preparation and analytical 
ultracentrifugal characteristics of the Lp lipoprotein, it was found that there 
was considerable interindividualheterogeneity among Lp lipoproteins isolated 
from a large number of people. It also became evident that Lp preparations 
from approximately 25~ of a group of about 60 individuals showed a double 
peak in ultracentrifuge diagrams in the area ordinarily occupied by the single 
Lp peak. The occurrence of the double peak was found to be reproducible 
in samples of serum drawn and tested from a given donor at different times. 
This report presents data to document the heterogeneity of the Lp 
lipoproteins from different individuals and to show that both the lipoproteins 
in the double variants carry Lp(a) specificity. 
MATERIALS AND METHODS 
Preparation of Lipoproteins 
Sera used in this study were purchased from institutionalized, healthy, male 
donors, of both the Caucasian and Black races. The men ranged in age from 
24 to 53 years, they were all on the same diet, they were not hyperlipemic, and 
they were not undergoing any drug treatment. 
4 LDL refers to low-density or ,8-1ipoprotein. HDL refers to high-density or ~-lipoprotein. 
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Lp lipoprotein samples were prepared according to the method of Harvie 
and Schultz (1970). This method is considered to be mild as it minimizes 
manipulation, consisting of one dextran sulfate precipitation step, two 
dialyses, and one gradient fractionation in the preparative ultracentrifuge. 
Samples were taken from the density gradient and dialyzed against the 
appropriate NaBr solution for analytical ultracentrifugation. 
Analytical Ultracentrifugation 
Analytical ultracentrifugation was done in a Beckman Model E ultracentri- 
fuge using the An-D rotor at 20 C either at 30,000 rpm (65,403 × ~) for runs at 
1.21 g/ml density or at 60,000 rpm (261,612 × ~) for runs at 1.004 g/ml density. 
All sedimentation coefficients (s) are in Svedberg units and were corrected for 
solvent viscosity, but not for the density. 
Density and Viscosity 
The density of the salt solutions used for gradients and analytical ultracentri- 
fugation was determined by measuring the dry weight of the solutions and 
combining these data with density data in the International Critical Tables 
(1928). Viscosity measurements were made according to the method of 
Ostwald (Findlay, 1935). 
Antisera 
Specific Lp(a) antisera were prepared~ absorbed, and checked by gel diffusion 
analysis as described previously (Schultz et al., 1968). Two antisera were used, 
one prepared against a double Lp variant, called anti-double Lp, and another 
prepared against a single Lp variant, called anti-single Lp. 
Concentration of Antisera 
Even though the titer of both antisera against the Lp antigen was high, it 
was not sufficiently high to absorb all the Lp activity of the Lp preparations 
used for the absorption tests. Therefore, both antisera were concentrated by 
partially purifying the globulins by precipitation for 1 hr at room temperature 
with saturated ammonium sulfate. The precipitate was redissolved in 0.15 M 
NaC1 in a smaller volume than the original sample and then dialyzed against 
0.15 M NaC1. 
Absorption Tests 
Lp lipoprotein samples were concentrated twofold by pervaporation for the 
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absorption tests so that after dilution in the test proper the final concentration 
of the Lp lipoprotein, if present, would be equal to that of the original isolated 
preparation. The antigen was dialyzed against 0.15 M NaC1. Absorption was 
done by mixing equal volumes of Lp preparation and antiserum and then 
incubating the mixture for 1 hr at 37 C followed by 24 hr at 4 C. The precipi- 
tate was removed by centrifugation at 2000 rpm in a clinical model table 
centrifuge for 30 min. 
The absorbed supernatant was dialyzed against 1.12 g/ml density NaBr 
overnight. Gradients were made for Lp isolation as was described under 
"Preparation of Lipoproteins" (Harvie and Schultz, 1970) except that the 
amount of solution of each layer was exactly scaled down from the 13 ml 
total volume of the No. 40 Spinco rotor tube to the 5 ml volume of the SW39 
Spinco rotor tube. The gradients were centrifuged 24 hr at 35,000 rpm (100,000 
x ~,) in the Spinco Model L ultracentrifuge. Tubes were cut to isolate the Lp 
lipoproteins at a position comparable to the Cut 6-9 of the No. 40 tube 
gradients which contained the Lp lipoprotein. Samples were dialyzed against 
1.004 g/ml density NaBr and subjected to analytical ultracentrifugation at 
60,000 rpm, 20 C. 
Statistical Procedures 
Correlation coefficient (r) was calculated according to Hald (1952, p. 89), and 
variance and standard deviation (so) according to Hald (1952, p. 72). Intra- 
individualized variance and SD were calculated for sedimentation coefficient 
data consisting of multiple Lp samples from a group of individuals each with 
a different mean but each individual tested in replicate (Hald, 1952, p. 426). 
RESULTS 
Evidence for Double Variants of  the Lp Lipoprotein 
During the investigation of over 100 Lp lipoprotein preparations, we have 
found that certain individuals showed the presence in the ultracentrifuge 
diagrams of two peaks sedimenting faster at density 1.004 g/ml than the 
accompanying ]%lipoprotein. We had visual evidence from our earlier studies 
that the Lp band in the preparative gradients might be double, but it was 
not until we started our present method of isolation using a minimum number 
of steps that the evidence was found in analytical ultracentrifuge diagrams. So 
far, of 34 different individuals whose sera were specifically examined for the 
presence of the two Lp lipoproteins, nine (26.5%) have shown the presence of 
the double peak. Figures 1 and 2 show ultracentrifuge diagrams and viscosity- 
corrected sedimentation coefficients (sl.0o4, 2o c) for these nine individuals. 
The Lp peaks are the two right-hand peaks in each diagram. The left-hand 
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Fig. 1. Analytical ultracentrifuge diagrams (t = 32 min) of six 
double Lp preparations. Viscosity-corrected sedimentation co- 
efficients at 1.004 g/ml density, 20 C, 60,000 rpm, are given below 
each Lp peak but not below the slow accompanying/Mipoprotein 
peak. 
peak is the accompanying/?-lipoprotein in the preparation, the amount of 
which varies from preparation to preparation. As indicated (Fig. 2), Lp 7-1, 
7-2, 7-3, and 7-4; Lp 8-1 and 8-2; and Lp 9-1 and 9-2 are replicate Lp 
isolations from three individuals made at least a month, and often more, 
apart. It is notable that among individuals the two Lp peaks in the ultra- 
centrifuge diagrams of the Lp preparations show variation both in sedimenta- 
tion rate and in amount relative to each other. These variations do not exist, 
however, or are at a minimum, in the sera from a single individual drawn and 
tested over a period of time. In this paper, the slower Lp peak (middle peak in 
the diagrams) will be referred to as Lp(a)-I and the faster peak as Lp(a)-2. 
After discovery of the double Lp lipoproteins, it was of interest to deter- 
mine if both peaks in the Lp region of the ultracentrifuge diagrams did have 
Lp(a) specificity and if antisera made against a double Lp variant contained 
antibodies specific to either of the two Lp lipoproteins. 
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Fig. 2. Analytical ultracentrifuge diagrams (t = 32 min) of eight double Lp prepara- 
tions from three individuals, 7, 8, and 9, tested in replicate over extended periods of 
time. Viscosity-corrected sedimentation coefficients at 1.004 g/ml density, 20 C, 
60,000 rpm, are given below each Lp peak but not below the slow accompanying 
fl-lipoprotein peak. 
The occurrence of the Lp(a) determinant on both Lp lipoproteins was 
investigated experimentally using the following absorption tests. Antiserum 
was prepared against the double Lp preparation shown in Fig. 3A (3B is a 
diluted sample of  3A) and was called anti-double Lp. Antiserum was also 
prepared against the single Lp preparation shown in Fig. 3C and was called 
anti-single Lp. The slow peak in the diagrams represents the accompanying 
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Fig. 3. Analytical ultracentrifuge diagrams, 1.004 g/ml density, 
20 C, 60,000 rpm, t = 28 rain, of (A) double Lp preparation A, 
(B) double Lp preparation A diluted 1 : 3, (C) single Lp prepara- 
tion C, (D) double Lp preparation A absorbed with homologous 
antiserum, and (E) double Lp preparation A absorbed with 





Fig. 4. Distribution of viscosity-corrected 
sedimentation coefficients at density 
1.004 g/ml, 20 C, 60,000 rpm, of 32 
single Lp lipoprotein preparations and 
14 double Lp lipoprotein preparations. 
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/%lipoprotein. Antisera made against these preparations were absorbed with 
/Mipoprotein prepared from an Lp(a)-"negative," i.e., Lp(a-) ,  individual so 
they had only antibodies of the Lp specificity present. A double Lp prepara- 
tion (Fig. 3A) was then absorbed with anti-double Lp and another sample of 
it with anti-single Lp. Figure 3D shows the double Lp preparation absorbed 
with anti-double Lp, and Fig. 3E shows the double Lp preparation absorbed 
with anti-single Lp. The removal of both Lp lipoproteins in the double Lp 
preparation by anti-single Lp serum indicates that Lp(a)-I and Lp(a)-2 
share a common Lp determinant, provided that the single Lp preparation was 
indeed single and did not contain any of the second Lp molecular species, 
which had not been detected by our methods. 
The presence of an antigenic determinant on one of the double Lp lipo- 
proteins not shared by the other was investigated using an antiserum prepared 
against a double Lp preparation. Samples of this antiserum were absorbed with 
a number of different single Lp preparations. If the anti-double Lp antiserum 
contained antibodies of two different specificities, only one of which was 
directed toward the Lp lipoprotein in the single Lp preparation used for 
absorption, then the antibodies of the second specificity should remain in the 
antiserum after the absorption procedure and be free to react with one of the 
Lp lipoproteins present in a double Lp preparation which is used to detect 
it. In none of a number of such experiments was there any evidence of any 
residual antibody in the anti-double Lp antiserum after absorption with 
single Lp preparations. There were several factors which may have affected 
the results of this experiment. When our anti-double Lp serum was made, we 
were not aware that we were immunizing with a double variant, and the man- 
ner of preparation of the double Lp antigen might have reduced the concen- 
tration or eliminated the second Lp. Therefore, the resulting antiserum might 
not have had antibodies with the new specificity. Furthermore, if the second 
Lp is a quantitative trait like Lp(a) (Harvie and Schultz, 1970), the increased 
concentrations of absorbing antigen needed to assure removal of one mole- 
cular species of Lp might have had a sufficient amount of the material from 
the second species to afford absorption even by what seemed to be a single 
Lp variant. There is a possibility that any given single Lp may be either Lp(a)- 
1 or Lp(a)-2, and therefore absorptions with different single Lp preparations 
should be done. 
The Heterogeneity of Lp Lipoproteins 
The viscosity-corrected sedimentation coefficient (S~.oo4, 20 c) of 60 Lp lipo- 
proteins, including 14 double variants, had a distribution shown in the 
bar graph of Fig. 4. The mean S~.oo4, 20 c of the Lp peak from the single 
variants was 15.8 ± 1.8 (n = 32), of the Lp(a)- 1 peaks was 13.5_+ 1.1, and of the 
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Lp(a)-2 peaks was 16.8+ 1.7. Although the distribution is quite broad, this 
breadth is probably not due to artifacts of preparation as the sD of 26 replicate 
determinations on Lp preparations made from ten individuals at times 
separated by a month or more was only 0.5s. 
The distribution in Fig. 4 is bimodal, accentuated by the presence of the 
double variants. There is almost no overlap of Lp(a)-I and Lp(a)-2, and it is 
interesting to speculate that in individuals having only one Lp peak this peak 
may turn out to be of either the Lp(a)-I or Lp(a)-2 variety. 
An attempt was made to study the density distribution of Lp prepara- 
tions. The method used was to determine the sedimentation coefficient at 
1.004 g/ml density and the flotation coefficient at 1.21 g/ml density. Densities 
of the Lp lipoproteins were calculated by extrapolating the data to the point 
where the sedimentation coefficient was zero. The data obtained are only 
approximations due to the fact that our Lp preparations always contain 
accompanying fl-lipoprotein. Although the separation of this fl-lipoprotein 
from Lp in the analytical ultracentrifuge was clear-cut at density 1.004 g/ml, 
at density 1.21 g/ml the density differences between the/~ and the Lp were 
"washed out" and the two floated as one peak in most cases. The mean 
density for 19 preparations of single Lp was 1.076+0.01 g/ml, with a range of 
1.060-1.094 g/ml. The mean densities for eight preparations of Lp(a)-I and 
Lp(a)-2 were 1.064 + 0.007 g/ml and 1.074 + 0.009 g/ml, respectively. Previous 
experiments on two preparations made by multiple gradient fractionation 
which contained only one Lp lipoprotein and no accompanying/%lipoprotein 
and in which densities were determined by sedimentation at two densities and 
flotation at two densities gave values of 1.068 g/ml and 1.070 g/ml. That the 
figures presented here are only approximations is indicated by the fact that the 
average density of eight Lp(a)-2 lipoproteins was 1.074 g/ml, which seems low 
considering the mean sedimentation coefficient of Lp(a)-2, which is 16.8s. 
Theoretically, there should be a near perfect correlation between sedimen- 
tation coefficient and density provided one is not dealing with an associating 
system. The correlation coefficient (r) calculated between 33 Sl.oo4, 20 c values 
and densities was 0.68, again pointing either to the approximate nature of the 
data or to the operation of unknown factors. If the correlation coefficient 
is calculated using data from single Lp variants, it is only slightly higher, i.e., 
0.71. 
DISCUSSION 
It has been apparent to investigators of Lp lipoprotein that this factor is very 
labile, denaturing readily during experimental manipulation (Harvie and 
Schultz, 1970; Simons et al., 1970). For this reason, we have chosen a method 
of preparation of Lp lipoprotein which minimizes manipulation, consisting 
of one precipitation step with dextran sulfate, two dialyses, and one gradient 
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fractionation in the preparative ultracentrifuge. Preliminary studies showed 
that the ultracentrifuge diagrams of Lp lipoprotein isolated by dextran sulfate 
precipitation did not differ from diagrams of Lp lipoprotein isolated by 
multiple preparative ultracentrifugal steps. Results of isolation of over 100 Lp 
preparations using these methods showed that the so-called accompanying 
fl-lipoprotein is not eliminated. Our studies have been done on samples 
containing this impurity, as it was evident that the Lp lipoprotein was readily 
distinguishable from it. We acknowledge that the presence of accompanying 
fl-lipoprotein probably influences the precise sedimentation rates and especially 
the flotation rate at density 1.21 g/ml. 
The different rates of sedimentation of the two Lp lipoproteins in the 
analytical ultracentrifuge could be due to the presence of two molecular species 
of Lp with identical composition of lipid and protein moieties but different 
molecular weights due to an association phenomenon. On the other hand, 
there could be present two molecular species of differing percentage of lipid 
and protein which would thus have different densities (and different molecular 
weights) and different sedimentation rates. Our preliminary density studies 
favor the latter explanation. At present, the knowledge of the chemical 
composition of Lp lipoproteins is more qualitative than quantitative. More 
precise data will be available only when Lp lipoproteins are obtained purified 
in larger amounts than are available now in a physical and chemical state 
approximating that which occurs in vivo. 
Reports have appeared indicating that seemingly purified Lp lipoprotein 
can be obtained by additional column chromatography (Simons et aL, 1970; 
Ehnholm et al., 1971; Utermann et al., 1972) and/or polyacrylamide gel 
electrophoresis (Garoff et al., 1970; Utermann and Wiegandt, 1970). No data 
have been presented which characterize these preparations by analytical 
ultracentrifugation or give chemical characteristics of multiple samples. Due 
to the cross-reactivity of Lp and fi-lipoprotein, antigen-antibody reactions 
are not sufficient proof of homogeneity. 
That our preparations are adequate for a study of characteristics of 
multiple preparations from the same and different individuals is substantiated 
by an intraindividual SD of the Sl.o04, 20 c of 0.5s, which is one-fourth to one- 
third of the SD of s of interindividual preparations. 
The appearance of the double Lp lipoprotein variants poses the possi- 
bility that we have discovered another lipoprotein polymorphism in human 
serum. So far, it is one without a specific antibody different from Lp(a), and 
therefore more effort is indicated to elucidate its specificity. The Lp(a)-2 
reported here could be a multimer of Lp(a)-l. It is not likely to be one of the 
disaggregation products reported by Utermann et aL (1972), as there is no 
evidence for non-lipid-containing components. The consistent finding of the 
double peaks in certain individuals argues for their natural occurrence. 
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